Bladder-sparing therapy for muscle-infiltrating bladder cancer

Nature Clinical Practice Urology

Volumn 5, Issue 7, 2008, Pages 368-375

  Pansadoro, Vito ^a   Emiliozzi, Paolo ^b  

^a Vincenzo Pansadoro Foundation   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; DOXORUBICIN; FLUOROURACIL; GEMCITABINE; METHOTREXATE; MITOMYCIN C; PACLITAXEL; VINBLASTINE;

BLADDER CANCER; BRACHYTHERAPY; CANCER INFILTRATION; CANCER INVASION; CANCER SURVIVAL; COMBINATION CHEMOTHERAPY; CYSTECTOMY; EVIDENCE BASED MEDICINE; FOLLOW UP; HUMAN; MONOTHERAPY; MULTIMODALITY CANCER THERAPY; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW; SURVIVAL RATE; SURVIVAL TIME; TRANSURETHRAL RESECTION; TREATMENT INDICATION; TREATMENT PLANNING;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; CYSTECTOMY; HUMANS; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PATIENT SELECTION; RADIOTHERAPY DOSAGE; REOPERATION; SURVIVAL ANALYSIS; URINARY BLADDER NEOPLASMS;

EID: 52449135526     PISSN: 17434270     EISSN: 17434289     Source Type: Journal    
DOI: 10.1038/ncpuro1145     Document Type: Review

References (49)

1. Nishiyama H et al. (2004) Clinical outcome of a large-scale multi-institutional retrospective study for locally advanced bladder cancer: A survey including 1,131 patients treated during 1990-2000 in Japan. Eur Urol 45: 176-181
2. Madersbacher S et al. (2003) Radical cystectomy for bladder cancer today - a homogeneous series without neoadjuvant therapy. J Clin Oncol 21: 690-696
3. Stein JP et al. (2001) Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients. J Clin Oncol 19: 666-675
4. Grob MB and Fair WR (2001) Partial cystectomy in the treatment of urologic and non-urologic malignancies. AUA Update Series XX 185-192
5. Sternberg CN et al. (2003) Can patient selection for bladder preservation be based on response to chemotherapy? Cancer 97 1644-1652
6. Herr HW and Scher HI (1994) Neoadjuvant chemotherapy and partial cystectomy for invasive bladder cancer. J Clin Oncol 12: 975-980
7. Kassouf W et al. (2006) Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: A contemporary review of the MD Anderson Cancer Center experience. J Urol 175: 2058-2062
8. O'Flynn JD et al. (1975) Transurethral resection for the assessment and treatment of vesical neoplasms: A review of 840 consecutive cases. Eur Urol 1: 38-40
9. Barnes RW et al. (1977) Survival following transurethral resection of bladder carcinoma. Cancer Res 37: 2895-2898
10. Herr HW (2001) Transurethral resection of muscle-invasive bladder cancer: 10-year outcome. J Clin Oncol 19: 89-93
11. Solsona E et al. (1998) Feasibility of transurethral resection for muscle infiltrating carcinoma of the bladder: Long-term followup of a prospective study. J Urol 159:95-99
12. Cowan RA et al. (2004) Radiotherapy for muscle-invasive carcinoma of the bladder: Results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy. Int J Radiat Oncol Biol Phys 59: 197-207
13. Hayter CR et al. (1999) A population-based study of the use and outcome of radical radiotherapy for invasive bladder cancer. Int J Radiat Oncol Biol Phys 45: 1239-1459
14. Abe T and Kanehira C (1999) Factors influencing treatment results of definitive radiotherapy following transurethral surgery for muscle-invasive bladder cancer [Japanese]. Nippon Igaku Hoshasen Gakkai Zasshi 59: 516-520
15. Nieuwenhuijzena JA et al. (2005) Survival after bladder preservation with brachytherapy versus radical cystectomy: A single institution experience. Eur Urol 48: 239-245
16. de Crevoisier R et al. (2004) Bladder-conserving surgery and interstitial brachytherapy for lymph node negative transitional cell carcinoma of the urinary bladder: Results of a 28-year single institution experience. Radiother Oncol 72: 147-157
17. Schlosser J et al. (1997) Conservative surgery and iridium 192 in stage pT2 bladder tumor. A 5-year follow up [French]. Prog Urol 7: 953-959
18. Wijnmaalen A et al. (1997) Muscle invasive bladder cancer treated by transurethral resection, followed by external beam radiation and interstitial iridium-192. Int J Radiat Oncol Biol Phys 39: 1043-1052
19. Thomas DJ et al. (1999) Radical transurethral resection and chemotherapy in the treatment of muscle-invasive bladder cancer: A long-term follow-up. BJU Int 83: 432-437
20. Angulo JC et al. (1996) Primary cisplatin, methotrexate and vinblastine aiming at bladder preservation in invasive bladder cancer: multivariate analysis on prognostic factors. J Urol 155: 1897-1902
21. Herr HW et al. (1998) Neoadjuvant chemotherapy and bladder sparing surgery for invasive bladder cancer: Ten-year outcome. J Clin Oncol 16: 1298-1301
22. Sternberg CN et al. (2003) Can patient selection for bladder preservation be based on response to chemotherapy? Cancer 97 1644-1652
23. Srougi M and Simon SD (1994) Primary methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy and bladder preservation in locally invasive bladder cancer: A 5-year follow-up. J Urol 151 593-597
24. de la Rosa F et al. (2002) Primary cisplatin, methotrexate and vinblastine chemotherapy with selective bladder preservation for muscle invasive carcinoma of the bladder: Long-term followup of a prospective study. J Urol 167: 2413-2418
25. Kachnic LA et al. (1997) Bladder preservation by combined modality therapy for invasive bladder cancer. J Clin Oncol 15: 1022-1029
26. Arias F et al. (2000) Chemoradiotherapy for muscle invading bladder carcinoma: Final report of a single institutional organ-sparing program. Int J Radiat Oncol Biol Phys 47: 373-378
27. Shipley WU et al. (2002) Selective bladder preservation by combined modality protocol treatment: Long-term outcomes of 190 patients with invasive bladder cancer. Urology 60: 62-67
28. Danesi DT et al. (2004) Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy: Long term results. Cancer 101: 2540-2548
29. Birkenhake S et al. (1998) Radiotherapy alone or radiochemotherapy with platin derivatives following transurethral resection of the bladder: Organ preservation and survival after treatment of bladder cancer. Strahlenther Onkol 174: 121-127
30. Kaufman DS et al. (2005) RTOG Protocol 99-06: Initial report of a phase I/II trial of selective bladder-conservation employing TURBT, accelerated irradiation sensitized with cisplatin and paclitaxel followed by ASCO 2005. Proc Annu Meet Am Soc Clin Oncol 23 S379
31. Tester W et al. (1993) Combined modality program with possible organ preservation for invasive bladder carcinoma: Results of RTOG protocol 85-12. Int J Radiation Oncology Biol Phys 25: 783-790
32. Housset M et al. (1993) Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: A prospective study. J Clin Oncol 11: 2150-2157
33. Fellin G et al. (1997) Combined chemotherapy and radiation with selective organ preservation for muscle-invasive bladder carcinoma: A single-institution phase II study. Br J Urol 80: 44-49
34. Prie L et al. (1998) Conservative treatment of infiltrating cancer of the bladder: Neoadjuvant chemotherapy and radiotherapy. Cancer Radiother 2: 62-66
35. Cervek J et al. (1998) Invasive bladder cancer: Our experience with bladder sparing approach. Int J Radiat Oncol Biol Phys 41 273-278
36. Vikram B et al. (1998) Rapidly alternating chemotherapy and radiotherapy instead of cystectomy for the treatment of muscle-invasive carcinoma of the urinary bladder: Long term results of a pilot study. Cancer 82: 918-922
37. Serretta V et al. (1998) The fate of patients with locally advanced bladder cancer treated conservatively with neoadjuvant chemotherapy, extensive transurethral resection and radiotherapy: 10-year experience. J Urol 159: 1187-1191
38. Radosevic-Jelic L et al. (1999) Concomitant radiotherapy and carboplatin in locally advanced bladder cancer. Eur Urol 36: 401-405
39. Olsburgh J and Whelan P (1999) Contemporary results of radical radiotherapy for bladder transitional cell carcinoma in a district general hospital. BJU Int 84: 1117
40. Hagan MP et al. (2003) RTOG 97-06: Initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy. Int J Radiat Oncol Biol Phys 57: 665-672
41. Hussain SA et al. (2004) Long-term results of a phase II study of synchronous chemoradiotherapy in advanced muscle invasive bladder cancer. Br J Cancer 90: 2106-2111
42. George L et al. (2004) Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy. Urology 64: 488-493
43. Sanchez-Ortiz RF et al. (2003) An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma. J Urol 169: 110-115
44. May M et al. (2004) Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder. Urol Nephrol 38: 231-235
45. Chang SS et al. (2003) Delaying radical cystectomy for muscle invasive bladder cancer results in worse pathological stage. J Urol 170:1085-1087
46. Hautmann RE (1998) Complications and results after cystectomy in male and female patients with locally invasive bladder cancer. Eur Urol 33. 23-24
47. Osen I et al. (1998) Prognostic factors in muscle-invasive bladder cancer treated with radiotherapy: An immunohistochemical study. Br J Urol 81: 862-869
48. Michaelson MD et al. (2004) Selective bladder preservation for muscle-invasive transitional cell carcinoma of the urinary bladder. Br J Cancer 90: 578-581
49. Matos T et al. (2000) Prognostic factors in invasive bladder carcinoma treated by combined modality protocol (organ-sparing approach). Int J Radiat Oncol Biol Phys 46: 403-409